Compounds > dextrothyroxine
Page last updated: 2024-08-20

dextrothyroxine and chronic COVID syndrome

dextrothyroxine has been researched along with chronic COVID syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Anderson, BJ; Beckman, KB; Belani, HK; Bhat, NS; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Griffiths, G; Hartman, KM; Huling, JD; Karger, AB; Klatt, NR; Liebovitz, DM; Lindberg, SM; Mehta, T; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, M; Puskarich, MA; Rose, MR; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Wirtz, EL1
Aminpour, M; Santin, AD; Scheim, DE; Tavernini, S; Tuszynski, JA; Vottero, P1
Singh, S; Yang, YF1

Trials

1 trial(s) available for dextrothyroxine and chronic COVID syndrome

ArticleYear
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
    The Lancet. Infectious diseases, 2023, Volume: 23, Issue:10

    Topics: Adult; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Fluvoxamine; Humans; Incidence; Ivermectin; Male; Metformin; Middle Aged; Outpatients; Post-Acute COVID-19 Syndrome; Pregnancy; SARS-CoV-2; Treatment Outcome

2023

Other Studies

3 other study(ies) available for dextrothyroxine and chronic COVID syndrome

ArticleYear
COVID-19 update: Metformin to prevent long COVID?
    The Medical letter on drugs and therapeutics, 2023, 05-29, Volume: 65, Issue:1677

    Topics: COVID-19; Humans; Hypoglycemic Agents; Ivermectin; Metformin; Post-Acute COVID-19 Syndrome; SARS-CoV-2

2023
Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
    International journal of molecular sciences, 2023, Jul-14, Volume: 24, Issue:14

    Topics: COVID-19; Fibrin; Fibrinogen; Hemostatics; Humans; Ivermectin; Molecular Docking Simulation; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Thrombosis

2023
Pharmacogenomic Landscape of Ivermectin and Selective Antioxidants: Exploring Gene Interplay in the Context of Long COVID.
    International journal of molecular sciences, 2023, Oct-23, Volume: 24, Issue:20

    Topics: Anthocyanins; Antioxidants; COVID-19; Humans; Ivermectin; MicroRNAs; Pandemics; Pharmacogenetics; Post-Acute COVID-19 Syndrome

2023